{"disease":{"id":"atopic-disorders","name":"atopic disorders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03409367","title":"A Community-based Assessment of Skin Care, Allergies, and Eczema","phase":"NA","overall_status":"COMPLETED","enrollment_count":1260,"lead_sponsor_name":"Oregon Health and Science University","has_results":true},{"nct_id":"NCT05334940","title":"Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT05932953","title":"Skin Tolerance of Medical Devices for Diabetes Monitoring and Treatment in Children With Type 1 Diabetes","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT04397081","title":"Atopic Diseases & Human Papilloma Virus","phase":"","overall_status":"COMPLETED","enrollment_count":239,"lead_sponsor_name":"Adana Numune Training and Research Hospital","has_results":false},{"nct_id":"NCT03050151","title":"Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":176,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT06390696","title":"Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Natural Resources Institute Finland","has_results":false},{"nct_id":"NCT03997175","title":"Effect of Modified Playground Environment on Health, Particularly Immune System","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of Helsinki","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}